How AI Could Make Every Disease A Rare Disease

How AI Could Make Every Disease A Rare Disease

Treating over 10,000 different rare conditions requires a radically new approach to drug discovery: artificial intelligence. There has been an encouraging trend in our understanding of rare diseases in recent years. The number of recognized rare diseases where the number of those affected is one in 2,000 people or fewer—has been steadily increasing. For the last decade, the number stood between 7,000 and 8,000, but thanks to new research, including RareX's Power of Being Counted report, the number now stands at 10,867. This does not mean more and more conditions are suddenly developing, to be clear; rather, our ability to understand and distinguish between them, or diagnose them, has improved. But this presents both a challenge and an opportunity for the biotech and pharma sectors.

Medigy Insights

Treating over 10,000 rare conditions requires a new approach to drug discovery: artificial intelligence (AI). The number of recognized rare diseases has increased to 10,867 from 7,000 to 8,000 due to improved diagnosis. This presents a challenge and an opportunity for biotech and pharma sectors. AI can expedite drug discovery by identifying drug targets, predicting adverse drug reactions, and personalizing treatments. It can also reduce the cost and time required for drug development and expand treatment options for patients.


Deploy this technology today


Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Apr 26, 2024 at 6:14am